Lambrechts, Sandrina <br/><br/>
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer.  [electronic resource] 

 -  BMC pharmacology & toxicology  Feb 2015 
 - 2 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2050-6511 
<br/><br/><label>Standard No.: </label>10.1186/s40360-015-0001-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia--chemically induced<br/>Carboplatin--administration & dosage<br/>Carrier Proteins--genetics<br/>Colony-Stimulating Factors--adverse effects<br/>DNA Repair--genetics<br/>Female<br/>Genotype<br/>Hematinics--adverse effects<br/>Humans<br/>Inactivation, Metabolic--genetics<br/>Middle Aged<br/>Multidrug Resistance-Associated Protein 2<br/>Neurotoxicity Syndromes--genetics<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Polymorphism, Single Nucleotide--genetics<br/>Thrombocytopenia--chemically induced<br/>Young Adult